Iron Metabolism in Cancer

被引:207
作者
Wang, Yafang [1 ]
Yu, Lei [1 ,2 ]
Ding, Jian [1 ]
Chen, Yi [1 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai 201203, Peoples R China
[2] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
基金
中国国家自然科学基金;
关键词
iron homeostasis; cancer; epigenetic regulation; tumor microenvironment; iron manipulating strategies; EPITHELIAL-MESENCHYMAL TRANSITION; GELATINASE-ASSOCIATED LIPOCALIN; TRANSFERRIN RECEPTOR 1; BREAST-CANCER; CELL-CYCLE; OXIDE NANOPARTICLES; HEPATOCELLULAR-CARCINOMA; MAGNETIC NANOPARTICLES; REGULATORY PROTEIN-1; PHOTOTHERMAL THERAPY;
D O I
10.3390/ijms20010095
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Demanded as an essential trace element that supports cell growth and basic functions, iron can be harmful and cancerogenic though. By exchanging between its different oxidized forms, iron overload induces free radical formation, lipid peroxidation, DNA, and protein damages, leading to carcinogenesis or ferroptosis. Iron also plays profound roles in modulating tumor microenvironment and metastasis, maintaining genomic stability and controlling epigenetics. in order to meet the high requirement of iron, neoplastic cells have remodeled iron metabolism pathways, including acquisition, storage, and efflux, which makes manipulating iron homeostasis a considerable approach for cancer therapy. Several iron chelators and iron oxide nanoparticles (IONPs) has recently been developed for cancer intervention and presented considerable effects. This review summarizes some latest findings about iron metabolism function and regulation mechanism in cancer and the application of iron chelators and IONPs in cancer diagnosis and therapy.
引用
收藏
页数:22
相关论文
共 199 条
[1]   Cell iron status influences macrophage polarization [J].
Agoro, Rafiou ;
Taleb, Meriem ;
Quesniaux, Valerie F. J. ;
Mura, Catherine .
PLOS ONE, 2018, 13 (05)
[2]   Iron Oxide Nanoparticles Induce Oxidative Stress, DNA Damage, and Caspase Activation in the Human Breast Cancer Cell Line [J].
Alarifi, Saud ;
Ali, Daoud ;
Alkahtani, Saad ;
Alhader, M. S. .
BIOLOGICAL TRACE ELEMENT RESEARCH, 2014, 159 (1-3) :416-424
[3]   NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis [J].
Alvarez, Samantha W. ;
Sviderskiy, Vladislav O. ;
Terzi, Erdem M. ;
Papagiannakopoulos, Thales ;
Moreira, Andre L. ;
Adams, Sylvia ;
Sabatini, David M. ;
Birsoy, Kivanc ;
Possemato, Richard .
NATURE, 2017, 551 (7682) :639-+
[4]   MUB40 Binds to Lactoferrin and Stands as a Specific Neutrophil Marker [J].
Anderson, Mark C. ;
Chaze, Thibault ;
Coic, Yves-Marie ;
Injarabian, Louise ;
Jonsson, Friederike ;
Lombion, Naelle ;
Selimoglu-Buet, Dorothee ;
Souphron, Judith ;
Ridley, Caroline ;
Vonaesch, Pascale ;
Baron, Bruno ;
Arena, Ellen T. ;
Tinevez, Jean-Yves ;
Nigro, Giulia ;
Nothelfer, Katharina ;
Solary, Eric ;
Lapierre, Valerie ;
Lazure, Thierry ;
Matondo, Mariette ;
Thornton, David ;
Sansonetti, Philippe J. ;
Baleux, Francoise ;
Marteyn, Benoit S. .
CELL CHEMICAL BIOLOGY, 2018, 25 (04) :483-+
[5]   Regulation of divalent metal transporter 1 (DMT1) non-IRE isoform by the microRNA Let-7d in erythroid cells [J].
Andolfo, Immacolata ;
De Falco, Luigia ;
Asci, Roberta ;
Russo, Roberta ;
Colucci, Simona ;
Gorrese, Marisa ;
Zollo, Massimo ;
Iolascon, Achille .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (08) :1244-1252
[6]   Non-Transferrin-Bound Iron (NTBI) Uptake by T Lymphocytes: Evidence for the Selective Acquisition of Oligomeric Ferric Citrate Species [J].
Arezes, Joao ;
Costa, Monica ;
Vieira, Ines ;
Dias, Vera ;
Kong, Xiao L. ;
Fernandes, Rui ;
Vos, Matthijn ;
Carlsson, Anna ;
Rikers, Yuri ;
Porto, Graca ;
Rangel, Maria ;
Hider, Robert C. ;
Pinto, Jorge P. .
PLOS ONE, 2013, 8 (11)
[7]   New signaling pathways for hepcidin regulation [J].
Arosio, Paolo .
BLOOD, 2014, 123 (10) :1433-1434
[8]   miR-20a regulates expression of the iron exporter ferroportin in lung cancer [J].
Babu, Kamesh R. ;
Muckenthaler, Martina U. .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2016, 94 (03) :347-359
[9]   High-Dose Deferoxamine Treatment Disrupts Intracellular Iron Homeostasis, Reduces Growth, and Induces Apoptosis in Metastatic and Nonmetastatic Breast Cancer Cell Lines [J].
Bajbouj, Khuloud ;
Shafarin, Jasmin ;
Hamad, Mawieh .
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2018, 17
[10]   Targeting STEAP1 Protein in Human Cancer: Current Trends and Future Challenges [J].
Barroca-Ferreira, J. ;
Pais, J. P. ;
Santos, M. M. ;
Goncalves, A. M. ;
Gomes, I. M. ;
Sousa, I. ;
Rocha, S. M. ;
Passarinha, L. A. ;
Maia, C. J. .
CURRENT CANCER DRUG TARGETS, 2018, 18 (03) :222-230